PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 214 filers reported holding PTC THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,723,961 | +130.4% | 42,389 | +174.5% | 0.08% | +186.2% |
| Q1 2023 | $748,107 | -53.7% | 15,444 | -63.5% | 0.03% | -50.8% |
| Q4 2022 | $1,616,232 | +1.3% | 42,343 | +33.3% | 0.06% | +5.4% |
| Q3 2022 | $1,595,000 | +60.3% | 31,771 | +27.9% | 0.06% | +86.7% |
| Q2 2022 | $995,000 | +35.7% | 24,841 | +26.5% | 0.03% | +7.1% |
| Q1 2022 | $733,000 | -37.1% | 19,640 | -32.9% | 0.03% | -37.8% |
| Q4 2021 | $1,165,000 | – | 29,260 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |